Barbara E. Souza
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Barbara E. Souza has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Jin-Chong Tan
Multifunctional Materials & Composites (MMC) Laboratory, Department of Engineering Science, University of Oxford, Oxford, UK
6 shared publications Annika F. Möslein
Multifunctional Materials & Composites (MMC) Lab, Department of Engineering Science, University of Oxford Parks Road, Oxford OX1 3PJ, United Kingdom
2 shared publicationsArun S. Babal
Multifunctional Materials & Composites (MMC) Laboratory, Department of Engineering Science , University of Oxford , Parks Road , Oxford OX1 3PJ , U.K.
2 shared publicationsJames D. Taylor
STFC Rutherford Appleton Laboratory ISIS Neutron and Muon Source Chilton, Didcot OX11 0QX, United Kingdom
2 shared publications- Kirill Titov
Multifunctional Materials and Composites (MMC) Laboratory Department of Engineering Science University of Oxford Parks Road Oxford OX1 3PJ UK
2 shared publications Mark D. Frogley
Diamond Light Source, Harwell Campus, Chilton, Oxford OX11 0DE, U.K.
2 shared publications
Latest Publications
- 24 February 2021
- Published by American Chemical Society (ACS) in ACS Applied Electronic Materials
- Vol. 3 (3) , 1191-1198
Broadband Dielectric Behavior of an MIL-100 Metal–Organic Framework as a Function of Structural Amorphization
- 24 February 2021
- Published by American Chemical Society (ACS) in ACS Applied Electronic Materials
- Vol. 3 (3) , 1191-1198
Broadband Dielectric Behavior of an MIL-100 Metal–Organic Framework as a Function of Structural Amorphization
- Open Access
- 29 June 2020
- Published by Royal Society of Chemistry (RSC) in CrystEngComm
- Vol. 22 (27) , 4526-4530
Mechanochemical approaches towards the in situ confinement of 5-FU anti-cancer drug within MIL-100 (Fe) metal–organic framework
Low-cost mechanochemistry methods for in situ confinement of “guest” drug molecules into a “host” metal–organic framework to yield nanoscale guest@host drug delivery systems.
- 29 June 2020
- Published by Royal Society of Chemistry (RSC) in CrystEngComm
- Vol. 22 (27) , 4526-4530
Open AccessMechanochemical approaches towards the in situ confinement of 5-FU anti-cancer drug within MIL-100 (Fe) metal–organic framework
Low-cost mechanochemistry methods for in situ confinement of “guest” drug molecules into a “host” metal–organic framework to yield nanoscale guest@host drug delivery systems.
- 12 June 2020
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 12 (27) , 30189-30197
MOF-Based Polymeric Nanocomposite Films as Potential Materials for Drug Delivery Devices in Ocular Therapeutics
Novel MOF-based polymer nanocomposite films were successfully prepared using Zr-based UiO-67 as a metal–organic framework (MOF) and polyurethane (PU) as a polymeric matrix. Synchrotron X-ray powder diffraction (SXRPD) analysis confirms the improved stability of the UiO-67 embedded nanocrystals, and scanning electron microscopy images confirm their homogeneous distribution (average crystal size ∼100–200 nm) within the 50 μm thick film. Accessibility to the inner porous structure of the embedded MOFs was completely suppressed for N2 at cryogenic temperatures. However, ethylene adsorption measurements at 25 °C confirm that at least 45% of the MOF crystals are fully accessible for gas-phase adsorption of nonpolar molecules. Although this partial blockage limits the adsorption performance of the embedded MOFs for ocular drugs (e.g., brimonidine tartrate) compared to the pure MOF, an almost 60-fold improvement in the adsorption capacity was observed for the PU matrix after incorporation of the UiO-67 nanocrystals. The [email protected] nanocomposite exhibits a prolonged release of brimonidine (up to 14 days were quantified). Finally, the combined use of SXRPD, thermogravimetric analysis (TGA), and Fourier transform infrared (FTIR) analyses confirmed the presence of the drug in the nanocomposite film, the stability of the MOF framework and the drug upon loading, and the presence of brimonidine in an amorphous phase once adsorbed. These results open the gate toward the application of these polymeric nanocomposite films for drug delivery in ocular therapeutics, either as a component of a contact lens, in the composition of lacrimal stoppers (e.g., punctal plugs), or in subtenon inserts.
- 12 June 2020
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 12 (27) , 30189-30197
MOF-Based Polymeric Nanocomposite Films as Potential Materials for Drug Delivery Devices in Ocular Therapeutics
Novel MOF-based polymer nanocomposite films were successfully prepared using Zr-based UiO-67 as a metal–organic framework (MOF) and polyurethane (PU) as a polymeric matrix. Synchrotron X-ray powder diffraction (SXRPD) analysis confirms the improved stability of the UiO-67 embedded nanocrystals, and scanning electron microscopy images confirm their homogeneous distribution (average crystal size ∼100–200 nm) within the 50 μm thick film. Accessibility to the inner porous structure of the embedded MOFs was completely suppressed for N2 at cryogenic temperatures. However, ethylene adsorption measurements at 25 °C confirm that at least 45% of the MOF crystals are fully accessible for gas-phase adsorption of nonpolar molecules. Although this partial blockage limits the adsorption performance of the embedded MOFs for ocular drugs (e.g., brimonidine tartrate) compared to the pure MOF, an almost 60-fold improvement in the adsorption capacity was observed for the PU matrix after incorporation of the UiO-67 nanocrystals. The [email protected] nanocomposite exhibits a prolonged release of brimonidine (up to 14 days were quantified). Finally, the combined use of SXRPD, thermogravimetric analysis (TGA), and Fourier transform infrared (FTIR) analyses confirmed the presence of the drug in the nanocomposite film, the stability of the MOF framework and the drug upon loading, and the presence of brimonidine in an amorphous phase once adsorbed. These results open the gate toward the application of these polymeric nanocomposite films for drug delivery in ocular therapeutics, either as a component of a contact lens, in the composition of lacrimal stoppers (e.g., punctal plugs), or in subtenon inserts.
- 14 May 2020
- Published by American Chemical Society (ACS) in ACS Sustainable Chemistry & Engineering
- Vol. 8 (22) , 8247-8255
Green Reconstruction of MIL-100 (Fe) in Water for High Crystallinity and Enhanced Guest Encapsulation
- 14 May 2020
- Published by American Chemical Society (ACS) in ACS Sustainable Chemistry & Engineering
- Vol. 8 (22) , 8247-8255
Green Reconstruction of MIL-100 (Fe) in Water for High Crystallinity and Enhanced Guest Encapsulation
- 6 January 2020
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 12 (4) , 5147-5156
Elucidating the Drug Release from Metal–Organic Framework Nanocomposites via In Situ Synchrotron Microspectroscopy and Theoretical Modeling
Nanocomposites comprising metal organic frameworks (MOFs) embedded in a polymeric matrix are promising carriers for drug delivery applications. While understanding the chemical and physical transformations of MOFs during the re-lease of confined drug molecules is challenging, this is central to devising better ways for controlled release of therapeutic agents. Herein we demonstrate the efficacy of synchrotron microspectroscopy to track the in situ release of 5-fluorouracil (5-FU) anticancer drug molecules from a [email protected]/polymer composite ([email protected]/polyurethane). Using experimental time-resolved infrared spectra jointly with newly developed density functional theory calculations, we reveal the detailed dynamics of vibrational motions underpinning the dissociation of 5-FU bound to the framework of HKUST-1 upon water exposure. We discover that HKUST-1 creates hydrophilic channels within the hydrophobic polyurethane matrix hence helping to tune drug release rate. The synergy between a hydrophilic MOF with a hydrophobic polymer can be harnessed to engineer a tunable nanocomposite that alleviates the unwanted burst effect commonly encountered in drug delivery.
- 6 January 2020
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 12 (4) , 5147-5156
Elucidating the Drug Release from Metal–Organic Framework Nanocomposites via In Situ Synchrotron Microspectroscopy and Theoretical Modeling
Nanocomposites comprising metal organic frameworks (MOFs) embedded in a polymeric matrix are promising carriers for drug delivery applications. While understanding the chemical and physical transformations of MOFs during the re-lease of confined drug molecules is challenging, this is central to devising better ways for controlled release of therapeutic agents. Herein we demonstrate the efficacy of synchrotron microspectroscopy to track the in situ release of 5-fluorouracil (5-FU) anticancer drug molecules from a [email protected]/polymer composite ([email protected]/polyurethane). Using experimental time-resolved infrared spectra jointly with newly developed density functional theory calculations, we reveal the detailed dynamics of vibrational motions underpinning the dissociation of 5-FU bound to the framework of HKUST-1 upon water exposure. We discover that HKUST-1 creates hydrophilic channels within the hydrophobic polyurethane matrix hence helping to tune drug release rate. The synergy between a hydrophilic MOF with a hydrophobic polymer can be harnessed to engineer a tunable nanocomposite that alleviates the unwanted burst effect commonly encountered in drug delivery.
- 18 February 2019
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 55 (27) , 3868-3871
Guest–host interactions of nanoconfined anti-cancer drug in metal–organic framework exposed by terahertz dynamics
A facile mechanochemical method was employed to accomplish one-pot encapsulation of anti-cancer drug 5-fluorouracil (5-FU as guest) in a metal–organic framework (HKUST-1 as host). Vibrational spectroscopy via inelastic neutron scattering was applied to probe guest–host interactions arising from nanoscale confinement. We compare 5-FU@HKUST-1 derived from in situ and ex situ encapsulation.
- 18 February 2019
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 55 (27) , 3868-3871
Guest–host interactions of nanoconfined anti-cancer drug in metal–organic framework exposed by terahertz dynamics
A facile mechanochemical method was employed to accomplish one-pot encapsulation of anti-cancer drug 5-fluorouracil (5-FU as guest) in a metal–organic framework (HKUST-1 as host). Vibrational spectroscopy via inelastic neutron scattering was applied to probe guest–host interactions arising from nanoscale confinement. We compare 5-FU@HKUST-1 derived from in situ and ex situ encapsulation.